ArticleScientific reports2026
Evaluation of innovative dual-layer modified polyethersulfone membranes in the control of biofouling.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study uniquely demonstrates the innovative combination of aminophenol and phenolic acids through laccase-catalyzed processes on polyethersulfone (PES) surfaces. Firstly, PES membranes were modified via laccase-catalyzed polymerization of 3-aminophenol (3-AP), then a second layer with either 4-hydroxybenzoic acid (B), gallic acid (G), syringic acid (S), or vanillic acid (V) was integrated using the same laccase-catalyzed polymerization method. The B/3-AP/PES and S/3-AP/PES membranes (using 4-hydroxybenzoic acid and syringic acid as the second modification layer) had better hydrophilicity as the contact angle was reduced from 44.1° (one-layered 3-AP/PES) to 23.8° and 27.9°, respectively, alongside significant increases in the root-mean-square (RMS) roughness (59 nm for unmodified PES vs. 180.2 and 385 nm for B/3-AP/PES and S/3-AP/PES, respectively). Atomic Force Microscopy (AFM) imaging revealed brush-like architectures for 3-AP/PES and B/3-AP/PES, while it was pancake-like in S/3-AP/PES. MIC testing showed that bacterial inhibition could reach 99.9%. Microbial evaluations of biofilm formation showed that B/3-AP/PES gave the highest reduction in the detached bacterial count (77%); this was concomitant with lower hemocytometer cell counts. Scanning Electron Microscopy (SEM) confirmed the reduction of bacterial adhesion. This study introduces a new approach of enzymatically grafting aminophenol layer as a stable anchoring platform for dual-layered modification by natural phenolic compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.